[HTML][HTML] Liver fibrosis: mechanistic concepts and therapeutic perspectives

N Roehlen, E Crouchet, TF Baumert - Cells, 2020 - mdpi.com
Liver fibrosis due to viral or metabolic chronic liver diseases is a major challenge of global
health. Correlating with liver disease progression, fibrosis is a key factor for liver disease …

Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention

S Lanini, A Ustianowski, R Pisapia, A Zumla… - Infectious Disease …, 2019 - id.theclinics.com
Viral Hepatitis - Infectious Disease Clinics Skip to Main Content Skip to Main Menu
Advertisement Infectious Disease Clinics Log in Register Log in Subscribe Claim Main menu …

[HTML][HTML] CDC recommendations for hepatitis C screening among adults—United States, 2020

S Schillie - MMWR. Recommendations and Reports, 2020 - cdc.gov
Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United
States. HCV is transmitted primarily through parenteral exposures to infectious blood or …

Virus Variation Resource–improved response to emergent viral outbreaks

EL Hatcher, SA Zhdanov, Y Bao, O Blinkova… - Nucleic acids …, 2017 - academic.oup.com
Abstract The Virus Variation Resource is a value-added viral sequence data resource
hosted by the National Center for Biotechnology Information. The resource is located at …

[HTML][HTML] Hepatitis C virus infection: host–virus interaction and mechanisms of viral persistence

DGI Chigbu, R Loonawat, M Sehgal, D Patel, P Jain - Cells, 2019 - mdpi.com
Hepatitis C (HCV) is a major cause of liver disease, in which a third of individuals with
chronic HCV infections may develop liver cirrhosis. In a chronic HCV infection, host immune …

Heterologous immunity: role in natural and vaccine-induced resistance to infections

B Agrawal - Frontiers in immunology, 2019 - frontiersin.org
The central paradigm of vaccination is to generate resistance to infection by a specific
pathogen when the vacinee is re-exposed to that pathogen. This paradigm is based on two …

HCV virology and diagnosis

S Roger, A Ducancelle, H Le Guillou-Guillemette… - Clinics and research in …, 2021 - Elsevier
Hepatitis C virus (HCV) infection is a major cause of severe liver disease including chronic
hepatitis, cirrhosis and hepatocellular carcinoma. The HCV burden in public health is …

Risk of hepatocellular carcinoma after hepatitis C virus cure

MA Luna-Cuadros, HW Chen, H Hanif… - World Journal of …, 2022 - pmc.ncbi.nlm.nih.gov
Hepatitis C virus (HCV) is a significant cause of hepatocellular carcinoma (HCC). The direct-
acting antivirals marked a new era of HCV therapy and are associated with greater than …

Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C

M Brzdęk, D Zarębska-Michaluk… - World Journal of …, 2023 - pmc.ncbi.nlm.nih.gov
Chronic infection with the hepatitis C virus (HCV) remains a major health problem affecting
approximately 58 million people worldwide. In the era of interferon (IFN)-based regimens …

Medicinal mushrooms: a comprehensive study on their antiviral potential

M Sevindik, C Bal, EC Eraslan, I Uysal… - Prospects in …, 2023 - prospects.wum.edu.pl
Microbial diseases have become quite common in recent years. The interest in new
antimicrobial drugs is increasing due to the possible side effects of synthetic drugs and the …